Alternative antigen processing pathways in anti-infective immunity

Current Opinion in Immunology

Volumn 9, Issue 4, 1997, Pages 462-469

  Reimann, Jörg ^a   Kaufmann, Stefan He ^a,b  

^a UNIVERSITY OF ULM   (Germany)

^b MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; IMMUNITY; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; REVIEW; T LYMPHOCYTE;

EID: 0030862076     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80096-9     Document Type: Article

References (48)

1. Unanue ER. Macrophages, antigen-presenting cells, and the phenomenon of antigen handling and presentation. Paul WE. Fundamental Immunology. 1993;111-143 Raven Press, New York.
2. Kaufmann SHE. Immunity to intracellular bacteria. Annu Rev Immunol. 11:1993;129-163.
3. Harty JT, Lenz LL, Bevan MJ. Primary and secondary immune responses to Listeria monocytogenes. Curr Opin Immunol. 8:1996;526-530.
4. Jondal M, Schirmbeck R, Reimann J. MHC class I-restricted CTL responses to exogenous antigens. of special interest Immunity. 5:1996;295-302 This minireview summarizes the evidence of processing exogenous antigens for MHC-I-restricted epitope presentation. It provides an overview of the experimental systems in which this has been demonstrated.
5. Song R, Harding CV. Roles of proteasomes, transporter for antigen presentation (TAP), and β2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. J Immunol. 156:1996;4182-4190.
6. Wick MJ, Pfeifer JD. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation. of outstanding interest Eur J Immunol. 26:1996;2790-2799 This paper shows that antigens from phagocytosed bacteria can be processed either in a vacuolar compartment, or in the cytosol, depending on the intrinsic properties of the protein antigen. The data in this paper are critical for interpreting all previously published data on endosomal versus cytosolic processing of exogenous ovalbumin (OVA).
7. Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ, Harding CV. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature. 361:1993;359-362.
8. Malaviya R, Twesten NJ, Ross EA, Abraham SN, Pfeifer JD. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. of special interest J Immunol. 156:1996;1490-1496 This paper shows for the first time the importance of mast cells for processing phagocytized exogenous antigen for MHC-I-restricted peptide presentation.
9. Ke Y, Kapp JA. Exogenous antigens gain access to the major histocompatibility complex class I processing pathway in B cells by receptor-mediated uptake. of special interest J Exp Med. 184:1996;1179-1184 This paper adds B cells to the list of APCs that can efficiently process antigen, which has been taken up by receptor-mediated endocytosis, for MHC-I-restricted peptide presentation.
10. Böhm W, Schimbeck R, Elbe A, Melber K, Diminsky D, Kraal G, Van Rooijen N, Barenholz Y, Reimann J. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. J Immunol. 155:1995;3313-3321.
11. + cytotoxic T lymphocytes. Eur J Immunol. 26:1996;2595-2600.
12. Shen Z, Reznikoff G, Dranoff G, Rock KL. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol. 158:1997;2723-2730.
13. Echtenacher B, Männel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature. 381:1996;75-77.
14. Nieland TJF, Tan MCA, van Muijen MM, Koning F, Kruisbeek AM, van Bleek GM. Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94. Proc Natl Acad Sci USA. 93:1996;6135-6139.
15. Sohirmbeck R, Reimann J. Peptide transporter-independent, stress protein-mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation. Eur J Immunol. 24:1994;1478-1486.
16. Suto R, Srivastava PK. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science. 269:1995;1585-1588.
17. Roman E, Moreno C. Synthetic peptides non-covalently bound to bacterial hsp70 elicit peptide-specific T-cell responses in vivo. Immunology. 88:1996;487-492.
18. Harding CV. Class I MHC presentation of exogenous antigens. J Clin Immunol. 16:1996;90-96.
19. Schirmbeck R, Böhm W, Melber K, Reimann J. Processing of exogenous heat-aggregated (denatured) or particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation. J Immunol. 155:1995;4676-4684.
20. 2m promotes a new cycle of peptide binding by maintaining MHC-la heavy chains on the cell surface in a peptide-receptive state.
21. Sugita M, Brenner MB. Association of the invariant chain with major histocompatibility complex class I molecules directs trafficking to endocytic compartments. J Biol Chem. 270:1995;1443-1448.
22. Vigna JL, Smith KD, Lutz CT. Invariant chain association with MHC class I. Preference for HLA class I/β2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove. J Immunol. 157:1996;4503-4510.
23. b does not induce an influenza-specific cytotoxic T lymphocyte response or recycle membrane-bound peptides. Eur J Immunol. 25:1995;1121-1124.
24. b in the ER lumen and on the cell surface. The paper demonstrates the dissociation of trimaric, presentation-competent MHC-la molecules on the cell surface, and the fate of the generated MHC-la heavy chains.
25. + T cell development in TAP1/β2-microglobulin double mutant mice. Int Immunol. 7:1995;975-984.
26. d molecules at the cell surface. J Exp Med. 178:1993;2035-2046.
27. d molecules capture peptides from endocytosed, exogenous antigens for MHC class I-restricted presentation. of outstanding interest Eur J Immunol. 26:1996;2812-2821 This paper provides the first evidence for the invovement of a subset of recycling, surface-associated MHC-la molecules in the capture of peptides generated during endosomal processing of exogenous antigen.
28. Lindner R, Unanue ER. Distinct antigen MHC class II complexes generated by separate processing pathway. of outstanding interest EMBO J. 15:1996;6910-6920 This important paper describes the first evidence for an alternative MHC-II processing pathway.
29. Portnoy DA, Chakraborty T, Goebel W, Cossart P. Molecular determinants of Listeria monocytogenes pathogenesis. Infect Immun. 60:1992;1263-1267.
30. Paterson Y, Ikonomidis G. Recombinant Listeria monocytogenes cancer vaccines. Curr Opin Immunol. 8:1996;664-669.
31. Darji A, Chakraborty T, Wehland J, Weiss S. Listeriolysin generates a route for the presentation of exogenous antigens by major histocompatibility complex class I. Eur J Immunol. 25:1995;2967-2971.
32. Mazzaccaro RJ, Gedde M, Jensen ER, van Santen HM, Ploegh HL, Rock KL, Bloom BR. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA. 93:1996;11786-11791.
33. Hiltbold EM, Safley SA, Ziegler HK. The presentation of class I and class II epitopes of listeriolysin O is regulated by intracellular localization and by intercellular spread of Listeria monocytogenes. J Immunol. 157:1996;1163-1175.
34. 2m-deficient mutant mice. It, therefore, appears that expansion of its intracellular habitat does not provide an additional advantage for the survival of this pathogen which apparently has adopted maximally to intraphagosomal living.
35. Hess J, Dietrich G, Gentschev I, Miko D, Goebel W, Kaufmann SHE. Protection against murine listeriosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the naturally somatic antigen superoxide dismutase. Infect Immun. 65:1997;1286-1292.
36. Hess J, Gentschev I, Miko D, Welzel M, Ladel C, Goebel W, Kaufmann SHE. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc Natl Acad Sci USA. 93:1996;1458-1463.
37. Szalay G, Hess J, Kaufmann SHE. Presentation of Listeria monocytogenes antigens by major histocompatibility complex class I molecules to CD8 cytotoxic T lymphocytes independent of listeriolysin secretion and virulence. Eur J Immunol. 24:1994;1471-1477.
38. Zwickey HL, Potter TA. Peptide epitopes from noncytosolic Listeria monocytogenes can be presented by major histocompatibility complex class I molecules. Infect Immun. 64:1996;1870-1872.
39. Kaufmann SHE. γδ and other unconventional T lymphocytes: what do they see and what do they do? Proc Natl Acad Sci USA. 93:1996;2272-2279.
40. Nataraj C, Brown ML, Poston RM, Shawar SM, Rich RR, Fischer Lindahl K, Kurlander RJ. H2-M3wt-restricted, Listeria monocytogenes-specific CD8 T cells recognize a novel, hydrophobic, protease-resistant, periodate-sensitive antigen. Int Immunol. 8:1996;367-378.
41. + cytotoxic T cells. J Immunol. 152:1994;5352-5360.
42. Gulden PH, Fischer P, Sherman NE, Wang W, Engelhard VH, Shabanowitz J, Hunt DF, Pamer EG. A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class lb molecule. of outstanding interest Immunity. 5:1996;73-79 See annotation [43].
43. + T cells.
44. Wang C-R, Castano AR, Peterson PA, Slaughter C, Fischer Lindahl K, Deisenhofer J. Nonclassical binding of formylated peptide in crystal structure of the MHC class lb molecule H2-M3. Cell. 82:1995;655-664.
45. Lenz LL, Bevan MJ. H2-M3 restricted presentation of Listeria monocytogenes antigens. Immunol Rev. 151:1996;107-121.
46. + T lymphocytes by vaccination with nonliving bacteria. Proc Natl Acad Sci USA. 92:1995;12389-12392.
47. Fischer Lindahl K, Byers DE, Dabhi VM, Hovik R, Jones EP, Smith GP, Wang C-R, Xiao H, Yoshino M. H2-M3, a full service class lb histocompatility antigen. Annu Rev Immunol. 15:1997;851-880.
48. Nataraj C, Kurlander RJ. Class lb MHC products in host immunity against Listeria monocytogenes. Res Immunol. 147:1996;524-531.